Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT06165380 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06165380
- Sponsor
- Li Zhang
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2026-08-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.